Trade in substandard and falsified medicines
According to WHO, 10.5% of medicines in low- and middle-income countries are substandard or falsified (SF), which has a multidimensional impact on public health as well as severe economic and socioeconomic consequences. Constrained access, weak technical capacity and poor governance contribute to th...
Váldodahkkit: | Hagen, N, Hauk, C, Heide, L |
---|---|
Eará dahkkit: | Brombacher, D |
Materiálatiipa: | Book section |
Giella: | English |
Almmustuhtton: |
Nomos
2022
|
Geahča maid
-
Identification of substandard and falsified medicines: influence of different tolerance limits and use of authenticity inquiries
Dahkki: Hauk, C, et al.
Almmustuhtton: (2021) -
Substandard and Falsified Medicines in Myanmar
Dahkki: Mirai Sakuda, et al.
Almmustuhtton: (2020-03-01) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Dahkki: Cavany, S, et al.
Almmustuhtton: (2023) -
The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance
Dahkki: Sean Cavany, et al.
Almmustuhtton: (2023-10-01) -
How to achieve international action on falsified and substandard medicines.
Dahkki: Attaran, A, et al.
Almmustuhtton: (2012)